Pakistan Offers Major Pharmaceutical Investment Opportunities to Chinese Companies: Mustafa Kamal

Independent Report
ISLAMABAD: Federal Minister for National Health Services Syed Mustafa Kamal has invited Chinese pharmaceutical companies to expand investment partnerships with Pakistani firms, highlighting Pakistan’s pharmaceutical sector as a promising destination for international investment.
Addressing the Pakistan-China B2B Investment Conference 2026, the minister said Pakistan’s strategic location and improving investment climate provide attractive opportunities for investors.
He expressed confidence that the Drug Regulatory Authority of Pakistan (DRAP) would achieve the World Health Organization’s Maturity Level 3 (ML3) accreditation by April 2027, enabling Pakistani pharmaceutical products to access more than 100 additional international markets.
The minister assured local and foreign investors of the government’s continued support to facilitate investment and strengthen Pakistan-China cooperation in the pharmaceutical sector.